Florida adult chat trials
If the patient is not being treated at one of the nearly 1,100 hospitals and clinics participating in the trial, the patient can be referred by their oncologist to one of those sites.
Participating labs include: Foundation Medicine, Inc. and Caris Life Sciences will identify potential MATCH participants from the large numbers of cancer patients whose tumors they currently test from about 1,100 hospitals and clinics that are taking part in the MATCH trial.
When a participating lab identifies a genetic change that is being studied in a MATCH treatment arm, it will include that information in the patient’s report that goes to the patient’s oncologist.
The report will identify MATCH as one of the options the oncologist can discuss with their patient.
The COMET study will gather data to determine whether increasing knowledge about the limitations and benefits of genetic testing could reduce a patient’s level of distress about the process.
COMET will not directly inform MATCH, nor will it affect how a patient is treated while in the MATCH trial.